Lupin Share Price
₹2182.20
as on
Lupin Stock Performance
as on January 9, 2026 at 4:01 pm IST
Day's Low
Day's High
₹2,156₹2,195
1.20%
Downside
0.59%
Upside
52 Week's Low
52 Week's High
₹1,795.2₹2,392.2517.73%
Downside
9.63%
Upside
Lupin share price movements today
- Previous Close
- ₹2,190.90
- Open
- ₹2,191.00
- Volume
- 9.30L
- Upper Circuit
- ₹2,409.90
- Lower Circuit
- ₹1,971.90
- Day's Low - High
- ₹2,156 - ₹2,195
- 52 Week Low - High
- ₹1,795.2 - ₹2,392.25
Lupin Historical Returns
- 1 Month Return
- + 6.17 %
- 3 Month Return
- + 11.38 %
- 1 Year Return
- -0.41 %
- 3 Year Return
- + 187.57 %
- 5 Year Return
- + 102.9 %
Lupin Fundamentals
as on January 9, 2026 at 4:01 pm IST
Market Cap
₹99,682.64 Cr
Return on Equity (ROE)
17.7
PE Ratio (TTM)
23.03
Return on capital employed (ROCE)
21.32
Industry PE ratio
42.25
Beta (LTM)
1.04
P/B Ratio
3.81
Dividend Yield
0.59
PEG Ratio
0.62
Quarterly Earnings Growth YOY
72.76
EPS (TTM)
72.41
Sector
Pharmaceuticals
Book Value
376.77
Technical Analysis
Bullish
View Technical Analysis
Lupin Stock Valuation
as on January 9, 2026 at 4:01 pm IST
Lupin in the last 5 years
Lowest (-6437.86x)
December 3, 2018
Today (23.03x)
January 9, 2026
Industry (42.25x)
January 9, 2026
Highest (517.33x)
December 2, 2022
Today’s Price to Earnings Ratio: 23.03x
Lupin Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lupin with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 99,682.64 | 20.58% | 0.63 | 3,306 | 22,707 | |
| BUY | 9,493.43 | -10.06% | 0.52 | 413 | 2,013 | |
| BUY | 69,620.69 | 4.84% | 0.60 | 3,483 | 31,723 | |
| HOLD | 90,047.88 | 16.25% | 0.61 | 4,614 | 23,241 | |
| BUY | 59,701.88 | 16.29% | 0.00 | 1,414 | 6,445 |
Analyst Recommendation on Lupin Stock
Based on 38 analysts
70.27%
Buy
21.62%
Hold
8.11%
Sell
Based on 38 analysts, 70.27% of analysts recommend a 'BUY' rating for Lupin. Average target price of ₹2285.45
Source: S&P Global Market Intelligence
Lupin Share Price Target
Get share price movements and forecasts by analysts on Lupin.
What analysts predicted
4.73%UPSIDE
Target Price
₹2285.45
Current Price
₹2182.2
Analyzed by
38 Analysts
High
₹2600
Target
₹2285.45
Low
₹1903
Lupin target price ₹2285.45, a slight upside of 4.73% compared to current price of ₹2182.2. According to 38 analysts rating.
Source: S&P Global Market Intelligence
Lupin Stock’s Investor Sentiment and Interest
Investment in Lupin Ltd Shares on INDmoney has dropped by -28.53% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Lupin Ltd Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Lupin Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Lupin Ltd Annual Profit & Loss
Figures in Rupees Crores
Lupin Ltd Cash Flow
Figures in Rupees Crores
Lupin Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Lupin Stock
Check out the Mutual Funds with significant holdings in Lupin.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Balanced Advantage Fund Direct Plan Growth Option | 1.1% | 5705582 | |
HDFC Large Cap Fund -Direct Plan - Growth Option | 2.37% | 4615980 | |
 Mirae Asset Large & Midcap Fund Direct Plan Growth | 2.05% | 4285561 | |
HDFC Flexi Cap Fund -Direct Plan - Growth Option | 0.93% | 4200000 | |
 Nippon India Pharma Fund - Direct Plan - Growth Plan | 7.36% | 2883991 |
Lupin Corporate Actions
View detailed summary of the earnings and dividend history of Lupin.
Lupin Ltd Earnings Results
Lupin Ltd’s net profit jumped 73.34% since last year same period to ₹1,477.92Cr in the Q2 2025-2026. On a quarterly growth basis, Lupin Ltd has generated 21.24% jump in its net profits since last 3-months.
Read More about Earnings ResultsLupin Ltd Dividends May,2025
In the quarter ending March 2025, Lupin Ltd has declared dividend of ₹12.00 per share on 14 May 2025 - translating a dividend yield of 0.55%.
Read More about Dividends
Indices Featuring Lupin Stock
Check stock indices that include Lupin.
Insights on Lupin Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, LUPIN stock has moved up by 4.7%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, LUPIN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 5.72K Cr → 7.13K Cr (in ₹), with an average increase of 10.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 772.52 Cr → 1.47K Cr (in ₹), with an average increase of 27.1% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 19.35% to 20.57% in Sep 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 21.0% return, outperforming this stock by 21.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 46.90% of holdings in Sep 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 21.25% to 20.49% in Sep 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 6.28% to 6.06% in Sep 2025 quarter
Lupin Stock Futures & Options Contracts
View the latest movement in Lupin Futures & Options, including strike prices, expiry dates, and percentage changes.
Lupin Options
Lupin Futures
About Lupin Ltd
The company's top products include a wide range of prescription and over-the-counter drugs, including antibiotics, cardiovascular medications, antidiabetics, and anti-asthmatics. Lupin Ltd also manufactures and markets a variety of branded products, including Metoject, Lupitac, and Lupizole. In addition, the company produces a number of popular generic drugs, such as Amlodipine, Montelukast, and Cetirizine.
Lupin Ltd is one of the world's leading manufacturers of APIs, with a portfolio that includes more than 200 APIs and intermediates. The company also produces a range of animal health products, such as veterinary vaccines, feed supplements, and pet care products.
Revenue: ₹6,831.43Cr as on September 2025 (Q2 FY26)
Net Profit: ₹1,484.83Cr as on September 2025 (Q2 FY26)
Listing date: 30 Nov, 1994
Chairperson Name: M D Gupta
| Organisation | Lupin Ltd |
| Industry | Pharmaceuticals |
| CEO | M D Gupta |
| E-voting on shares | Click here to vote |
FAQs
What is Lupin share price today?
Lupin share price today stands at ₹2182.2 as on at the close of the market. Lupin share today touched a day high of ₹2195 and a low of ₹2156.
What is the 52 week high and 52 week low range for Lupin share?
Lupin touched a 52 week high of ₹2392.25 and a 52 week low of ₹1795.2. Lupin share price today i.e. is closed at ₹2182.2, which is -8.78% down from its 52 week high and 21.56% up from its 52 week low.
What is Lupin's market capitalisation today?
Lupin market capitalisation is ₹99,682.64 Cr as on .
How to buy Lupin shares?
To buy Lupin shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for LUPIN or Lupin Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Lupin shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Lupin trading volume today?
Lupin trading volume is 9.30L as on . This means that 9.30L shares of Lupin were bought and sold on the stock market during today's trading session.